Vesal Yaghoobi

5PUBLICATIONS
60CO-AUTHORS
Immunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 05, 2024
Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma.

Thazin N Aung, Jonathan Warrell, Sandra Martinez-Morilla

|Aug 14, 2023
Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer.

Myrto Moutafi, Georgia-Angeliki Koliou, George Papaxoinis

|Mar 24, 2023
Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.

Thazin N Aung, Niki Gavrielatou, Ioannis A Vathiotis

|Apr 04, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.

Kim R M Blenman, Michal Marczyk, Thomas Karn

|Sep 01, 2021
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer.

Ioannis A Vathiotis, Myrto K Moutafi, Prajan Divakar

Pageof 1